<ѻýҕl>Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S.ѻýҕl> Findings suggest patients with SCLC are not screened for LEMS, despite their association Nov 02, 2023
<ѻýҕl>ACS: Millions More Should Get Lung Cancer Screeningѻýҕl> Notably, new recommendations say it doesn't matter when a person quit smoking Nov 01, 2023
<ѻýҕl>Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPCѻýҕl> Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
<ѻýҕl>Potential Cure for Sickle Cell Clears Hurdle for Approvalѻýҕl> FDA advisors suggest the benefits of gene therapy outweigh risks of off-target editing Oct 31, 2023
<ѻýҕl>Personalized Intervention Helps CRC Screening Decisions for Older Adultsѻýҕl> Patients receiving intervention were less likely to undergo screening if benefits were low Oct 31, 2023
<ѻýҕl>The Exciting Potential of Antibody-Drug Conjugates in Lung Cancerѻýҕl> Roy Herbst, MD, PhD, leads a discussion on ADCs targeting TROP2, HER2, and HER3 Oct 30, 2023 video
<ѻýҕl>FDA Reviewers Question Safety of Sickle Cell Gene Therapyѻýҕl> Efficacy results "strongly positive," but unintended off-target effects a question Oct 30, 2023
<ѻýҕl>FDA OKs First Drug for Nasopharyngeal Carcinomaѻýҕl> Toripalimab approved in combination with first-line chemo, and as monotherapy after progression Oct 30, 2023
<ѻýҕl>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deathsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 30, 2023
<ѻýҕl>Chinese Compound for MI?; Knee Pain Managementѻýҕl> Also in TTHealthWatch: a new colorectal cancer screening test Oct 28, 2023 podcast
<ѻýҕl>Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDSѻýҕl> News, features, and commentary about cancer-related issues Oct 27, 2023
<ѻýҕl>Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCCѻýҕl> Follow-up results from phase II study show 12-month EFS rate of 89% in stage II-IV disease Oct 25, 2023
<ѻýҕl>Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPCѻýҕl> Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
<ѻýҕl>New Options Challenge Standard Treatments in EGFR-Mutant NSCLCѻýҕl> Amivantamab-based regimens improved oncologic outcomes, but with more side effects Oct 25, 2023
<ѻýҕl>Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FITѻýҕl> ColoSense test outperforms fecal immunochemical testing in phase III trial Oct 25, 2023
<ѻýҕl>ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancerѻýҕl> Adjuvant alectinib reduces disease-free survival hazard by 76% Oct 24, 2023
<ѻýҕl>Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancersѻýҕl> Still some unanswered questions about benefit over other drug regimens, expert says Oct 24, 2023
<ѻýҕl>Randomized Trial Backs HIF-2a Inhibition in Advanced RCCѻýҕl> After immunotherapy-TKI failure, belzutifan produces better outcomes versus everolimus Oct 24, 2023
<ѻýҕl>More Data Support Adding Immunotherapy to Chemo in Advanced Endometrial Cancerѻýҕl> PFS doubled and OS improved, driven by mismatch repair-deficient disease Oct 23, 2023
<ѻýҕl>Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancerѻýҕl> Tisotumab vedotin reduced risk of death by 30% compared with chemotherapy Oct 23, 2023
<ѻýҕl>Targeting KRAS in NSCLC: Recent Progress and New Approachesѻýҕl> Roy Herbst, MD, PhD, leads a discussion on current and emerging treatments available Oct 23, 2023 video
<ѻýҕl>Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancerѻýҕl> Standard dose of sotorasib plus panitumumab reduced risk of progression by 51% vs standard care Oct 23, 2023
<ѻýҕl>Is It a Sports Injury, or Something More Serious?ѻýҕl> Osteoscarcomas can present to any clinical setting, pediatric researcher says Oct 23, 2023
<ѻýҕl>New First-Line Standard for Lung Cancers With EGFR Exon 20 Insertionsѻýҕl> Adding amivantamab to chemotherapy improved PFS, induced more rapid and durable responses Oct 23, 2023
<ѻýҕl>'Practice-Changing' Data in Locally Advanced Cervical Cancerѻýҕl> Strategies involving immunotherapy, induction chemo move the needle for first time in decades Oct 23, 2023
<ѻýҕl>RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLCѻýҕl> Two randomized studies demonstrate significantly improved PFS against standard regimens Oct 22, 2023
<ѻýҕl>Landmark Trial Produces New First-Line Standard for Advanced Bladder Cancerѻýҕl> Enfortumab vedotin-pembrolizumab doubles OS, PFS versus chemotherapy Oct 22, 2023
<ѻýҕl>Bi-Specific T-Cell Engager Active in Small-Cell Lung Cancer in Third Line and Beyondѻýҕl> Tarlatamab achieves 40% overall response rate at the dose selected for continued evaluation Oct 22, 2023
<ѻýҕl>Suzanne Somers' Legacy Tainted by Celebrity Medical Misinformationѻýҕl> The actress harnessed the power of traditional media like social media influencers do today Oct 22, 2023
<ѻýҕl>Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancerѻýҕl> Durvalumab plus olaparib, or alone, paired with chemo boosts PFS in DUO-E trial Oct 21, 2023
<ѻýҕl>Tebentafusp's OS Benefit in Uveal Melanoma Holds Up at 3 Yearsѻýҕl> And early ctDNA reductions correlated with survival Oct 21, 2023
<ѻýҕl>Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfersѻýҕl> Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
<ѻýҕl>Pembrolizumab in First-Line Boosts PFS in HER2-Positive Stomach Cancerѻýҕl> But label update planned after potential harm observed in PD-L1-negative subgroup Oct 20, 2023
<ѻýҕl>Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativityѻýҕl> Two-thirds of transplant-eligible patients met endpoint with isatuximab/KRd Oct 19, 2023
<ѻýҕl>Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatmentѻýҕl> News, features, and commentary about cancer-related issues Oct 19, 2023
<ѻýҕl>Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia Aѻýҕl> "Strategy will probably be practice-changing," says expert Oct 18, 2023
<ѻýҕl>Senators Grill NIH Director Nominee on Drug Prices, Gender-Affirming Careѻýҕl> Monica Bertagnolli, MD, makes her case during confirmation hearing Oct 18, 2023
<ѻýҕl>Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train?ѻýҕl> It's time for clear guidelines Oct 18, 2023
<ѻýҕl>What Caused the Pigmented Spot on Teen Boy's Eye?ѻýҕl> Authors discuss how best to diagnose and manage him, given the absence of any symptoms Oct 17, 2023
<ѻýҕl>Pembrolizumab Wins FDA Approval in Operable Lung Cancerѻýҕl> Checkpoint inhibitor demonstrated significant survival improvement in perioperative setting Oct 17, 2023